Research press release


Nature Communications

Virology: Inhibiting MERS coronavirus spread in cultured cells


今回、Shibo Jiangたちは、ウイルスの細胞への侵入を引き起こすMERS-CoVタンパク質と相互作用できる短いペプチド(タンパク質断片)を設計した。このペプチドは、培養細胞で使用されると、細胞のMERS-CoV感染を効率的に抑制できる。


Development of a molecule capable of inhibiting the spread of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in cultured cells is reported this week in Nature Communications.

Shibo Jiang and colleagues designed a short peptide (protein fragment) capable of interacting with MERS-CoV protein responsible for virus entry into the cells. When used in cultured cells, this peptide could efficiently block the infection of cells with MERS-CoV.

Middle East Respiratory Syndrome Coronavirus emerged over a year ago in the Middle East causing outbreaks of a SARS-like illness with a high case fatality rate. The reports of its person-to-person transmission through close contacts have raised a global concern about its pandemic potential. Therefore the development of drugs capable of inhibiting its spread is of great importance and this study may provide a step towards this goal. It is not yet clear, however, whether the molecule reported here will also be effective in blocking virus infection in animal models of the disease.

doi: 10.1038/ncomms4067

「Nature 関連誌注目のハイライト」は、ネイチャー広報部門が報道関係者向けに作成したリリースを翻訳したものです。より正確かつ詳細な情報が必要な場合には、必ず原著論文をご覧ください。

メールマガジンリストの「Nature 関連誌今週のハイライト」にチェックをいれていただきますと、毎週最新のNature 関連誌のハイライトを皆様にお届けいたします。